desipramine has been researched along with Brugada ECG Pattern in 1 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sheikh, M | 1 |
| Kanjwal, K | 1 |
| Kasmani, R | 1 |
| Chutani, S | 1 |
| Maloney, JD | 1 |
1 other study available for desipramine and Brugada ECG Pattern
| Article | Year |
|---|---|
Simultaneous ST-segment elevation in inferior and precordial leads following ingestion of a lethal dose of desipramine: a novel Brugada-like EKG pattern.
Topics: Brugada Syndrome; Bundle-Branch Block; Combined Modality Therapy; Desipramine; Disease Progression; | 2010 |